KLSO vs. BPCR, TV2H, KRM, WCW, ADA, ALGW, WINV, TFG, NBDG, and PEY
Should you be buying Kelso Group stock or one of its competitors? The main competitors of Kelso Group include BioPharma Credit (BPCR), Thames Ventures VCT 2 Healthcare Shs (TV2H), KRM22 (KRM), Walker Crips Group (WCW), Adams (ADA), Alpha Growth (ALGW), Worsley Investors (WINV), Tetragon Financial (TFG), NB Distressed Debt New Glb (NBDG), and Princess Private Equity (PEY). These companies are all part of the "asset management" industry.
Kelso Group (LON:KLSO) and BioPharma Credit (LON:BPCR) are both small-cap financial services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment, analyst recommendations and community ranking.
5.8% of Kelso Group shares are held by institutional investors. Comparatively, 41.2% of BioPharma Credit shares are held by institutional investors. 59.9% of Kelso Group shares are held by company insiders. Comparatively, 6.3% of BioPharma Credit shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
BioPharma Credit has a net margin of 79.90% compared to Kelso Group's net margin of 59.53%. Kelso Group's return on equity of 39.82% beat BioPharma Credit's return on equity.
BioPharma Credit received 84 more outperform votes than Kelso Group when rated by MarketBeat users.
In the previous week, BioPharma Credit's average media sentiment score of 1.20 beat Kelso Group's score of 0.00 indicating that BioPharma Credit is being referred to more favorably in the news media.
BioPharma Credit has higher revenue and earnings than Kelso Group. BioPharma Credit is trading at a lower price-to-earnings ratio than Kelso Group, indicating that it is currently the more affordable of the two stocks.
Kelso Group has a beta of 1.63, meaning that its share price is 63% more volatile than the S&P 500. Comparatively, BioPharma Credit has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500.
Summary
BioPharma Credit beats Kelso Group on 7 of the 13 factors compared between the two stocks.
Get Kelso Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for KLSO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Kelso Group Competitors List
Related Companies and Tools
